Jungehülsing M, Volling P
Universitäts-HNO-Klinik Köln.
HNO. 1994 May;42(5):280-7.
Squamous cell carcinomas of the head and neck from 50 untreated patients were analyzed for rearranged or amplified proto-oncogenes by Southern blot hybridization. The bcl-1 and hst genes were coamplified 8- to 32-fold in 5 of 46 patients (11%) and the c-erb A1 and c-erb B2 genes 32-fold in 1 of 46 patients (2%). Eight to 16-fold amplification of c-myc was observed in 4 of 46 tumor samples (8%), while 4-fold amplification of Ha-ras was found in 2 of 46 tumor samples (4%). There was one patient with a 64-fold c-erb B2 amplification without accompanying c-erb A1 amplification. RNA-expression analysis using Northern blot and poly-A-+RNA techniques did not reveal any changes in the RNA expression of c-erb A1 while c-erb B2, hst and bcl-1 were not expressed at all. No Ki-ras or N-myc amplification was observed, nor was any rearrangement of the above-mentioned oncogenes found. Clinical correlation existed between tumor stage and oncogene amplification: patients with stage I and II disease (IUCC,AJCC) showed no amplification at all, whereas 14 patients with stage III and IV disease showed amplified oncogenes (P = 0.015,chi 2-test). In contrast, there was no correlation between oncogene amplification and disease development (observed over a minimum period of 3 years), nor could amplification be correlated with other clinical parameters (sex, tumor site, -histology) for any of the oncogenes.(ABSTRACT TRUNCATED AT 250 WORDS)
对50例未经治疗的头颈部鳞状细胞癌患者的肿瘤进行分析,采用Southern印迹杂交法检测原癌基因的重排或扩增情况。46例患者中有5例(11%)的bcl-1和hst基因共扩增8至32倍,46例患者中有1例(2%)的c-erb A1和c-erb B2基因扩增32倍。46个肿瘤样本中有4例(8%)观察到c-myc基因扩增8至16倍,46个肿瘤样本中有2例(4%)发现Ha-ras基因扩增4倍。有1例患者c-erb B2基因扩增64倍,而无c-erb A1基因伴随扩增。采用Northern印迹和聚腺苷酸RNA技术进行RNA表达分析,结果显示c-erb A1的RNA表达无变化,而c-erb B2、hst和bcl-1根本未表达。未观察到Ki-ras或N-myc基因扩增,上述原癌基因也未发现重排情况。肿瘤分期与原癌基因扩增之间存在临床相关性:I期和II期(国际抗癌联盟、美国癌症联合委员会)患者未出现任何扩增,而14例III期和IV期患者出现原癌基因扩增(P = 0.015,卡方检验)。相反,原癌基因扩增与疾病进展(至少观察3年)之间无相关性,且任何原癌基因的扩增均与其他临床参数(性别、肿瘤部位、组织学)无关。(摘要截短至250字)